Itraconazole Capsules 130 mg(Supra Bioavailable Formulation) – FUNGWON SB 130 Capsules

FUNGWON SB 130 Capsules
Composition:- Itraconazole SB 130 mg

FUNGWON SB 130 Capsules – The composition of Itraconazole Capsules IP 130 mg(Supra bioavailable formulation) is a triazole antifungal that works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to fungal cell death. The supra bioavailable formulation enhances absorption and therapeutic efficacy at lower doses, making it more effective and patient-friendly. It is indicated for both superficial and systemic fungal infections.

Key Points of Itraconazole Capsules 130 mg(Supra Bioavailable Formulation) – FUNGWON SB 130 Capsules

• Improved Bioavailability: Supra bioavailable formulation ensures higher absorption and consistent therapeutic levels with lower doses compared to conventional itraconazole formulations.
• Broad-Spectrum Antifungal Action: Effective against a wide range of fungal infections, including systemic and superficial mycoses.
• Reduced Gastrointestinal Side Effects: Optimized formulation enhances patient compliance by minimizing GI discomfort.

Can be Prescribed by:

• Infectious Disease Specialists
• Dermatologists
• Internal Medicine Specialists
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.